Exited position

Two Sigma Investments, LP’s Elevance Health Inc Formerly (ANTM) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Two Sigma Investments, LPVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ1 2016Earliest verified positive filing snapshot
Latest statusExited positionBased on the latest supported relationship state
Peak shares1.19MHighest verified quarter-end share count
Quarters reported17Verified quarters with shares above zero
What happened?

Two Sigma Investments, LP first reported Elevance Health Inc Formerly in Q1 2016. The reported position was increased and reduced across later filings. The latest verified relationship event shows that Two Sigma Investments, LP sold the entire position in Q4 2025, and the stock is no longer reported in the latest verified portfolio.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q4 2025
Sold the entire position−110.49K shares · No shares reported at quarter-end
Q3 2025
Sold 63.5% of the position−192.17K shares · 110.49K shares remained
Filing context

Quarter-end price $323.12

Q2 2025
Bought 998.1% more+275.10K shares · 302.66K shares reported after the change
Filing context

Quarter-end price $388.96

Q1 2025
Sold 94.5% of the position−473.93K shares · 27.56K shares remained
Filing context

Quarter-end price $434.96

Q4 2024
Bought 247.7% more+357.26K shares · 501.49K shares reported after the change
Filing context

Quarter-end price $368.90

Q3 2024
Bought 312.9% more+109.31K shares · 144.24K shares reported after the change
Filing context

Quarter-end price $520.00

Portfolio importance

How important was Elevance Health Inc Formerly in Two Sigma Investments, LP’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Last reported portfolio weight0.1%Q3 2025
Last reported rank#421Rank unavailable
Peak portfolio weight0.7%Q2 2016
Best historical rank#9Q2 2023
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified investor filingQ2 2026 · filed 2026-08-14
Open SEC filing ↗

Coverage is bounded to the institution’s top reported positions and material events rather than every security in each Form 13F. The filing reflects reportable U.S.-listed holdings, not Two Sigma’s complete trading book, models, short positions, exact trade dates or execution prices. Options are reported separately.